Breast imaging devices market seen reaching $7.24 billion by 2030

The global breast imaging devices market is projected to rise from $5.6 billion in 2026 to $7.24 billion by 2030, driven by more breast cancer screening, broader use of digital mammography and new AI tools. North America led the market in 2025, while Asia-Pacific ranked second.

Why it matters: - Breast imaging devices are central to early breast cancer detection, which improves treatment outcomes and survival rates. - Rising breast cancer incidence is expanding demand for screening, diagnosis and follow-up imaging. - The market’s projected growth signals more spending on digital, AI-enabled and non-ionizing imaging systems.

What happened: - The breast imaging devices market is expected to grow from $5.27 billion in 2025 to $5.6 billion in 2026. - The market is forecast to reach $7.24 billion by 2030. - The 2025-2026 growth rate is 6.3%, and the 2026-2030 growth rate is projected at 6.7%. - The Business Research Company published the outlook on July 29, 2026. - The report covers breast imaging devices used for screening, diagnosis, surgical intervention and breast health support. - The report also includes a free sample and the full market report.

The details: - Historic growth has been supported by higher awareness of breast cancer screening, more diagnostic imaging centers, wider adoption of digital mammography, increased healthcare spending and ultrasound advances. - Forecast growth is tied to investment in AI-powered diagnostic tools, demand for earlier breast cancer detection, growth in outpatient imaging services, personalized breast care and non-ionizing imaging innovation. - Major trends include AI-assisted image analysis, broader use of 3D and digital breast tomosynthesis, multimodal imaging platforms, minimally invasive imaging diagnostics and earlier-stage cancer identification. - The World Health Organization estimates breast cancer affects about 2.1 million women each year and causes the highest number of cancer-related deaths among women globally. - ASCO reported in February 2023 that breast cancer accounted for one in three new cancer diagnoses among women in the U.S. - ASCO estimated 297,790 women would be diagnosed with invasive breast cancer in 2023, and 55,720 cases would be non-invasive breast cancer. - North America held the largest share of the breast imaging devices market in 2025. - Asia-Pacific ranked second in 2025. - The report also tracks South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook points to a shift from conventional screening toward faster, more precise and less invasive imaging workflows. - AI and multimodal platforms are emerging as the clearest competitive battlegrounds as providers look to improve detection and workflow efficiency. - The regional ranking suggests the U.S. and Canada remain the biggest demand centers, while Asia-Pacific continues to scale as screening access expands.

What's next: - Growth is likely to continue as clinics and hospitals add AI-assisted tools, tomosynthesis and outpatient imaging capacity. - Vendors will likely compete on image quality, diagnostic speed, integration and support for earlier cancer detection. - The company’s 2026 market reports add market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and trend analysis.